Molecular epidemiology of Coxiella burnetii from ruminants in Q fever outbreak, the Netherlands. by Roest, H.I.J. et al.
Q fever is a zoonosis caused by the bacterium Coxiella 
burnetii. One of the largest reported outbreaks of Q fever 
in humans occurred in the Netherlands starting in 2007; 
epidemiologic investigations identifi ed small ruminants as 
the source. To determine the genetic background of C. 
burnetii in domestic ruminants responsible for the human 
Q fever outbreak, we genotyped 126 C. burnetii–positive 
samples from ruminants by using a 10-loci multilocus 
variable-number tandem-repeat analyses panel and 
compared them with internationally known genotypes. One 
unique genotype predominated in dairy goat herds and 1 
sheep herd in the human Q fever outbreak area in the south 
of the Netherlands. On the basis of 4 loci, this genotype 
is similar to a human genotype from the Netherlands. This 
fi nding strengthens the probability that this genotype of C. 
burnetii is responsible for the human Q fever epidemic in 
the Netherlands.
Q fever is a zoonosis caused by Coxiella burnetii, an intracellular gram-negative bacterium that is 
prevalent throughout the world (1). Domestic ruminants 
are considered the main reservoir for Q fever in humans 
(2). However, other animal species, including pet animals, 
birds, and several species of arthropods, can be infected 
by C. burnetii and cause human cases of Q fever (2–5). 
The main clinical manifestations of Q fever in goats and 
sheep are abortion and stillbirth. In cattle, Q fever has been 
associated with sporadic abortion, subfertility, and metritis 
(4,6). With an abortion, up to 1 billion C. burnetii per gram 
of placenta can be excreted (7). Most animal species that 
carry C. burnetii show no symptoms (4). Transmission to 
humans occurs mainly through inhalation of contaminated 
aerosols (4,5,8–10).
Recently, 2 DNA-based methods for typing C. burnetii 
were reported (11–13). Multispacer sequence typing is 
based on DNA sequence variations in 10 short intergenic 
regions and can be performed on isolated C. burnetii 
strains or directly on extracted DNA from clinical samples 
(12,14,15). Multilocus variable-number tandem-repeat 
analyses (MLVA) is based on variation in repeat number 
in tandemly repeated DNA elements on multiple loci in the 
genome of C. burnetii and might be more discriminatory 
than multispacer sequence typing (13,15). MLVA also can 
be performed on C. burnetii strains (11,15) or directly on 
DNA extracted from clinical samples (16). A total of 17 
different minisatellite and microsatellite repeat markers 
have been described (11).
Starting in 2007, the Netherlands has been confronted 
with one of the largest Q fever outbreaks in the world, 
involving 3,921 human cases in 4 successive years. On 28 
dairy goat farms and 2 dairy sheep farms, abortion storms 
(with abortion rates up to 80%) caused by Q fever were 
diagnosed during 2005–2009. These small ruminants are 
considered the source of the human Q fever outbreak in 
the Netherlands (17). The connection between Q fever 
abortion storms in small ruminants and human Q fever 
cases is based primarily on epidemiologic investigations 
(18–21). A limited investigation by genotyping with 
MLVA recently showed that farms and humans in the 
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Molecular Epidemiology of C. burnetii
Netherlands are infected by multiple different, yet closely 
related, genotypes of C. burnetii (16).
Although dairy goats and dairy sheep appear to be the 
source of the human Q fever outbreak in the Netherlands, 
no information is available about the genetic background of 
C. burnetii in these populations. This knowledge is essential 
for gaining insight into the molecular epidemiology of the 
organism and the origin of the outbreak, as well as for 
outbreak management purposes.
Our objective was to show the genetic background 
of C. burnetii in domestic ruminants responsible for the 
human Q fever outbreak. This information is necessary to 
evaluate the epidemiologic link between the source and 
human cases and to compare the outbreak genotypes with 
internationally known genotypes. During 2008–2010, a 
total of 125 C. burnetii–positive samples from 14 dairy 
goat farms, 1 dairy cattle farm, and 2 sheep farms were 
typed by MLVA. In addition, we show the geographic 
distribution of these C. burnetii genotypes across the 
Netherlands and compare the genotypes with what is 
internationally known.
Materials and Methods
Animal Samples
Our study comprised 14 dairy goat farms (farms A–E, 
H, J, M, N, O, P, Q, AE, and AF), 1 dairy cattle farm 
(farm R), and 2 sheep farms (1 dairy sheep farm Y and 1 
sheep farm Z) sampled during the Q fever outbreak in the 
Netherlands (Table 1; Figure 1). On 12 of the 14 dairy goat 
farms, multiple abortions had occurred. On 2 dairy goat 
farms (farms J and M) and on the dairy sheep farm (farm 
Y), no abortions had occurred. On 1 dairy cattle farm and 
on the sheep farm (farm Z), C. burnetii was detected in a 
placenta after abortion. One goat farm (farm AG) sampled 
in 2001 was included with an archived histologic section 
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Table 1. Overview of Coxiella burnetii genotyping results for farms sampled during human Q fever outbreak, the Netherlands, 2007–
2010*
Farm
ID
Animal
species
Approximate 
herd size 
Year of 
sampling
Approximate 
abortions in year 
of sampling, % Sample type 
No.
samples
tested
No. samples 
included in 
study 
MLVA typing results 
MLVA
ID
No.
samples 
A Dairy goats 617 2008 25 Vaginal swabs 20 9 CbNL01 7
CbNL05 1
CbNL07 1
B Dairy goats 598 2008 20 Vaginal swabs 20 5 CbNL01 5
C Dairy goats 546 2008 25 Vaginal swabs 20 20 CbNL01 20
D Dairy goats 1,498 2008 19 Vaginal swabs 39 7 CbNL01 6
CbNL04 1
E Dairy goats 1,568 2008 8 (2007) Fetal tissue 3 3 CbNL01 1
CbNL09 1
CbNL11 1
H Dairy goats 606 2008 80 Vaginal swabs 13 8 CbNL01 7
CbNL02 1
J Dairy goats 459 2008 None Vaginal swabs 3 3 CbNL01 2
CbNL08 1
M Dairy goats 769 2008 None Vaginal swabs 2 1 CbNL10 1
N Dairy goats 1,187 2009 25 Vaginal swabs 20 20 CbNL01 20
Placenta 1 1 CbNL01 1
O Dairy goats 83 2009 7 Vaginal swabs 40 16 CbNL01 14
CbNL03 1
CbNL06 1
Milk 1 1 CbNL01 1
P Dairy goats 548 2009 10 Vaginal swabs 20 6 CbNL01 6
Q Dairy goats 340 2009 10 Vaginal swabs 25 19 CbNL01 19
AE Dairy goats 500 2007 >5 Placenta 1 1 CbNL12 1
AF Dairy goats 2,000 2007 >5 Placenta 1 1 CbNL01 1
AG Dairy goats 590 2001 >5 Paraffin-
embedded
placenta
1 1 1
R Dairy cattle 70 2007 <5 Placenta 1 1 CbNL13 1
Y Dairy sheep 184 2010 None Vaginal swabs 5 1 CbNL10 1
Bulk tank milk 
sample
1 1 CbNL10 1
Z Sheep 2 2009 50 Placenta 1 1 CbNL01 1
*ID, identification; MLVA, multilocus variable-number tandem-repeat analysis. 
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of paraffi n-embedded placenta from an abortion outbreak 
caused by C. burnetii infection.
Vaginal swabs and milk samples from dairy goats and 
dairy sheep were sent to the national reference laboratory for 
notifi able animal diseases (the Central Veterinary Institute, 
part of Wageningen UR) by the Dutch Food and Consumer 
Product Safety Authority in accordance with the regulation 
in place at that time. These samples were submitted for 
confi rmation testing of farms with clinically suspected Q 
fever (farms A–D, N, O, P, and Q), for tracing the source 
of human Q fever cases (because of proximity to human 
case-patients, farms H, J, and M) or for bulk tank milk 
monitoring (farm Y). Samples of immunohistochemically 
confi rmed Q fever–positive goat and sheep placentas 
(farms N, AE, AF, and Z) and fetal tissue (farm E) were 
provided by the Animal Health Service, including 1 
archived histologic section of paraffi n-embedded placenta 
from a C. burnetii abortion outbreak in a goat farm in 2001 
(farm AG), which was diagnosed retrospectively (22). The 
sampled dairy goat farms represent 60% of the farms with 
known abortion problems during 2007–2009.
Testing of Samples before MLVA Typing
DNA was extracted from vaginal swabs and milk by 
using Chelex resin (InstaGene; Bio-Rad, Hercules, CA, 
USA). A vaginal swab tip or 200 μL of milk was added 
to 400 μL of Chelex suspension and incubated and shaken 
for 30 min at 56°C, followed by an incubation step for 8 
min at 100°C. The clarifi ed supernatant was used for PCR 
and MLVA. DNA from placentas was extracted by using a 
DNA tissue kit (DNeasy Blood and Tissue Kit; QIAGEN, 
Hilden, Germany). DNA from the paraffi n-embedded 
placenta was extracted by using MagneSil Genomic Fixed 
Tissue System (Promega, Madison, WI, USA).
All samples were tested by an in-house real-time PCR 
directed toward the C. burnetii–specifi c IS1111a element 
(23). An inhibition control was constructed by using 
the primes of the IS1111a element (Table 2). PCR was 
performed on a 7500 Fast Real Time PCR system (Applied 
Biosystems, Foster City, CA, USA) by using 400 nmol/L 
of primers and 200 nmol/L of probes in 7 μL PerfeCTa 
Multiplex qPCR Supermix, uracil-N-glycosylase (2×) 
(New England Biolabs, Ipswich, MA, USA] with Low Rox 
dye (Quanta BioSciences, Gaithersburg, MD, USA ), 1 μL 
of inhibition control, 5 μL of sample, and 7 μL of water. 
An initial uracil DNA glycosylase (UDG) incubation for 
5 min at 45°C and denaturation/activation for 60 s at 95°C 
was followed by 40 cycles of denaturation for 10 s at 95°C, 
annealing for 30 s at 60°C. Results were generated with 
7500 Fast System Software (Applied Biosystems).
MLVA Typing
MLVA typing was performed by using a selection of 
10 of the 17 loci described by Arricau-Bouvery et al. (11) 
according to the Multiple Loci VNTR Analysis databases 
for genotyping (http://minisatellites.u-psud.fr/MLVAnet/
querypub1.php), except that Ms12 was omitted because of 
poor performance, and Ms24 was added (Table 2). New 
primers were designed for Ms27 and Ms28 to improve 
performance. The annotation of Ms30, Ms31, and Ms36 
was updated (P. Le Flèche, pers. comm.).
The PCR amplifi cation was performed by using an 
Applied Biosystems 9700 thermocycler in a total volume 
of 25 μL containing 1× reaction buffer, 1 U True Start Taq 
DNA polymerase (Fermentas, Glen Burnie, MD, USA), 
2 mmol/L MgCl2, 0.2 mmol/L of each nucleotide (dATP, 
dGTP, dCTP, dUTP), 0.5 μmol/L of each primer, 0.5 U 
UDG (New England Biolabs), and 2–5 μL template. An 
initial UDG incubation for 5 min at 37°C and denaturation/
activation for 2 min at 95°C was followed by 40 cycles 
of denaturation for 30 s at 95°C, annealing for 30 s at 
60/65°C, elongation for 30 s at 72°C, followed by a fi nal 
extension step for 5 min at 72°C. After the amplifi cation, 
0.5 U UDG inhibitor (New England Biolabs) was added to 
the PCRs to prevent further UDG activity. Up to 4 different 
PCR products with different fl uorescent dyes were diluted, 
depending on the PCR effi ciency, and pooled. From 
these pooled PCR products, 4 μL was mixed with 15 μL 
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Figure 1. Map of the Netherlands showing locations of farms 
sampled during the Q fever outbreak, 2007–2010. Farms are 
indicated by letter and ruminant species (black squares, goats; 
black triangles, sheep; black star, cattle); genotypes of Coxiella 
burnetii found per farm are indicated by bars at each farm’s location. 
The height of the bar indicates numbers of isolates per genotype.
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of Hi-Di formamide (Applied Biosystems) and 0.5 μL of 
GeneScan 600 LIZ Size Standard (Applied Biosystems). 
After denaturation for 3 min at 96°C the samples were 
cooled on ice. The PCR products were separated on a 3130 
Genetic Analyzer (Applied Biosystems) with a 36-cm array 
by using POP7 polymer.
The fragments were sized by using GeneMapper 
version 4.0 software (Applied Biosystems). The accuracy 
of the sizing obtained by capillary electrophoresis was 
determined by comparing sequencing data from the 
reference strain with the obtained fragment size from the 
capillary electrophoresis and corrected if necessary. The 
number of repeats for each locus was determined on the 
basis of the published and corrected annotation of the 
various loci (Table 2). Non–whole repeat numbers were 
rounded off mathematically. Reproducibility was checked 
with positive controls.
Data Analysis
The reference strain Nine Mile was used as reference 
(11). Analyses were performed, including only genotypes 
of C. burnetii containing <2 loci with missing values. 
Numerical typing data were imported into BioNumerics 
v 6.1 (Applied Maths, Sint-Martens-Latem, Belgium) 
and analyzed with the multistate categorical similarity 
coeffi cient by using unweighted pair group method with 
arithmetic mean clustering. Missing values were imported 
as question marks. The genotypic diversity of the population 
under study was calculated by using the adapted Simpson 
index of diversity (Hunter-Gaston diversity index [HGDI]) 
(11,24).
Found MLVA patterns based on the number of repeats 
per locus were called MLVA types and identifi ed as 
CbNLxx. We compared MLVA types with MLVA types 
in the publicly accessible Multiple Loci VNTR Analysis 
databases for genotyping: Coxiella2007 and Coxiella2009_
Netherlands (access date 2001 Jan 11). The Nine Mile 
strain was used as reference.
Results
The study comprised 122 samples from 15 dairy goat 
farms, 2 samples from 1 dairy sheep farm, and 1 sample 
each from 1 sheep farm and 1 dairy cattle farm were 
included in this study (Table 1). Of the farms sampled 
during the outbreak, 13 were situated in the southern part of 
the Netherlands; 3 dairy goat farms (farms M, N, and AE) 
and 1 dairy sheep farm (farm Y) were located outside this 
area (Figure 1). From the 238 Q fever PCR-positive samples 
from the farms in this study, 125 (53%) yielded a genotype 
with <2 missing values: 52 with a complete genotype, 48 
with 1 missing value, and 25 with 2 missing values. 113 
(47%) PCR-positive samples represented partial genotypes 
with 3–10 missing values. From the paraffi n-embedded 
placenta (farm AG), only a partial genotype could be 
shown, with 6 repeats on Ms03 and 10 repeats on Ms34.
We distinguished 13 genotypes in the 125 samples 
(CbNL01–CbNL13; Table 1; Figures 1, 2). All C. burnetii 
genotypes could be associated with abortion, except for 2 
(CbNL10, farm M and Y; and CbNL08, farm J; Figure 1). 
The relationship between the genotypes in all samples is 
shown in Figure 2, including the genotype of the reference 
strain Nine Mile and the reference genotype of the reference 
strain Nine Mile from Arricau-Bouvery et al. (11), which 
were identical.
The 13 genotypes are separated in 2 clusters (Figure 
2). One cluster containing a genotype represented by 111 
(90%) of the samples (CbNL01); 1 genotype (CbNL10) 
represented by 3 samples (1 from a dairy goat farm and 
2 from a dairy sheep farm); and 10 genotypes (CbNL02–
CbNL09 and CbNL11) represented by 1 sample, all 
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Table 2. Primers and probes used in the PCR for detecting Coxiella burnetii in clinical samples and loci and primers for MLVA of C.
burnetii, the Netherlands, 2007–2010* 
Identification 
Temp, 
°C 
Primer sequence for MLVA, with label indicated, 5? ? 3? 
Forward Reverse 
Primers IS1111a 60 CATCACATTGCCGCGTTTAC GGTTGGTCCCTCGACAACAT 
Probe IS1111a 60 AATCCCCAACAACACCTCCTTATTCCCAC  
Probe inhibition control 60 ACATAATCTCTCCGACCCCACACTTCCATAC  
Cbu0448_ms03_12bp_7U_229bp 60 6-FAM-TTGTCGATAAATCGGGAAACTT CACTGGGAAAAGGAGAAAAAGA 
Cbu1963_ms21_12bp_6U_210bp 60 NED-AGCATCTGCCTTCTCAAGTTTC TGGGAGGTAGAAGAAAAGATGG 
Cbu1980_ms22_11bp_6U_246bp 60 PET-GGGGTTTGAACATAGCAATACC CAATATCTCTTTCTCCCGCATT 
Cbu0259_ms24_7bp_27U_344bp 65 VIC-ATGAAGAAAGGATGGAGGGACT GATAGCCTGGACAGAGGACAGT 
Cbu0838_ms27_6bp_4U_320bp† 65 6-FAM-GGGTCAGGTGGCGGGTGTG TTCTCGCAAACGTCGCACTAACTC 
Cbu0839_ms28_6bp_6U_480bp† 60 VIC-TAGAAACCGATAATCCCCTTGACA ATTCCGCCGCCATTGAG 
Cbu1351_ms30_18bp_6U_306bp‡ 60 NED-ATTTCCTCGACATCAACGTCTT AGTCGATTTGGAAACGGATAAA 
Cbu1418_ms31_7bp_5U_285bp‡ 60 PET-GGGCATCTAATCGAGATAATGG TTTGAGAAAATTTTGGGTGCTT 
Cbu1471_ms34_6bp_5U_210bp 60 6-FAM-TGACTATCAGCGACTCGAAGAA TCGTGCGTTAGTGTGCTTATCT 
Cbu1941_ms36_9bp_4U_477bp‡ 65 VIC-GAAACCAGTCTTCCCTCAACAG ATAACCGTCATCGTCACCTTCT 
*MLVA, multilocus variable-number tandem-repeat analyses; temp, annealing temperature. 
†Different primer set from the proposed set by Arricau-Bouvery et al. (11). 
‡Updated after personal communication with Le Flèche, Université Paris-Sud, Orsay Cedex, France. 
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from dairy goat farms. The second cluster was distinctly 
separated from the other cluster, representing 2 genotypes 
in 1 dairy goat sample (CbNL12), in 1 dairy cattle sample 
(CbNL13) and the paraffi n-embedded placenta. In samples 
from dairy goat farms with abortion problems, the same 
genotype (CbNL01) was present in 110 (91%) of 121 
samples. One sheep sample also showed this genotype 
(farm Z). The geographic distribution of the genotypes 
according to the location of the originating farm is given 
in Figure 1. The relationship between the genotypes found 
in this study and the internationally known genotypes are 
presented in the phylogenetic trees in Figure 3 on the basis 
of 4 loci and in Figure 4 on the basis of 9 loci.
Discussion
We performed MLVA typing of C. burnetii based on 
10 loci on a large number of Q fever–positive samples to 
show the genetic background of C. burnetii in the domestic 
ruminants associated with the Q fever outbreak in humans in 
the Netherlands. In 125 (53%) of 237 samples, an adequate 
genotype for C. burnetii was generated. Previously, MLVA 
typing was performed on C. burnetii strains after primary 
isolation and cultivation (11,13,15) or, in the Netherlands, 
on only 11 clinical samples from humans, sheep, and goats 
with a selected number of 3 loci (16).
The main drawback of typing on clinical samples is 
the variable quality and amount of DNA. These drawbacks 
infl uence the typability of samples, resulting in partial 
genotypes; whether the missing values are caused by 
insuffi cient DNA concentrations and quality or by an 
absence of loci is unclear. If loci are absent, partial genotypes 
also are expected to be found in samples with high DNA 
loads. Such is not the case in our study. Typing of placenta 
material that contains high quantities of C. burnetii, as well 
as vaginal swabs with PCR cycle threshold (Ct) values <32, 
yielded complete genotypes. In samples with Ct values of 
32–34, only partial genotypes were obtained. Samples with 
a Ct value >34 were poorly typable.
Arricau-Bouvery et al. (11) calculated diversity indices 
for the 17 loci used in the MLVA, which varied from 0.28 
for locus Ms22 to 0.86 for locus Ms34. The HGDI for the 
combined panels 1 and 2 of the MLVA typing method 
for C. burnetii can be calculated on 0.99 and for panel 2 
on 0.92. These HGDIs are in the upper part of the 0.438–
0.997 range reported by Hunter and Gaston (24) for typing 
methods for various bacteria and yeasts.
The high diversity indices for the MLVA of C. burnetii 
indicate a high discriminating power, and this capability 
makes MLVA typing suitable for distinguishing C. burnetii 
isolates. With this highly discriminatory typing method, we 
found that 1 genotype of C. burnetii predominated on all 
dairy goat farms in the southern part of the Netherlands. 
On 12 of 14 dairy goat farms, this genotype was found 
in 91% of samples, varying per farm from 33% (farm E) 
to 100% (farms B, C, N–Q, Table 1, Figures 1 and 2). 
Although the sample size was small compared with the 
number of animals on the farm (Table 1), these data show 
that 1 genotype was far more common than other genotypes 
found on these farms. The 9 other genotypes occurred once, 
each representing only 0.8% of all found genotypes on dairy 
goat farms. The most predominant genotype was found on 
all 11 dairy goat farms in the southern Netherlands and on 
a farm in the eastern part of the country (farm N). This 
fi nding strongly suggests a clonal spread of C. burnetii with 
this predominant genotype over the dairy goat farms in the 
southeastern part of the Netherlands.
The clonal spread of 1 genotype of C. burnetii 
could be explained by 2 phenomena. First, the dairy goat 
industry in the Netherlands sharply increased from almost 
100,000 dairy goats in 2000 to >230,000 dairy goats on 
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Figure 2. Phylogenetic tree with genotypes of Coxiella burnetii of all 
samples in the study, the Netherlands, on the basis of 10 multilocus 
variable-number tandem-repeat analyses (MLVA). Repeats per 
locus are shown; open spots indicate missing values. NM, Nine 
Mile reference strain.
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≈350 farms in 2009 (17). Most of these goats were bred 
in the Netherlands, which probably resulted in a microbial 
relationship between many of the dairy goat herds. In this 
theory, the C. burnetii strain with the most predominant 
genotype was present in the Netherlands for a long period 
before the abortion problems in dairy goats started in 2005. 
This theory is not supported by the results of the typing of 
the paraffi n-embedded placenta from an aborted dairy goat 
who in 2001. The typing result differs on 2 loci from the 
most predominant genotype found in this study. Second, 
clonal spread could have been facilitated by emergence of 
a genotype of C. burnetii causing abortion in dairy goats 
that could then spread successfully over the dense goat 
population in the southeastern part of the country. Whether 
this genotype is more virulent is subject to research.
On the basis of comparison of MLVA types on 4 loci 
(Figure 3), CbNL01–06 could not be distinguished and 
were similar to the genotype of a person in the Netherlands 
(QPK2) and 2 genotypes from persons in France (Cb#88, 
Cb#97). The sample from a person in the Netherlands 
is derived from patient 2 reported by Klaassen et al. 
(16). Patient 2 is the farmer of farm A, where genotype 
CbNL01 predominated, as well as CbNL05 (Table 1). 
This shows a genetic link between the C. burnetii DNA 
from the farmer and his abortive goats, which suggests 
that the farmer was infected by his own goats. However, 
this link is based on only 4 loci on 1 human sample. To 
further confi rm the link between dairy goats and humans, 
more samples need to be typed with more MLVA loci to 
increase the discriminatory power.
The human sample with ID QKP6 is the same sample 
as that from patient 4 reported by Klaassen et al. (16) 
and is most closely related to CbNL07. Human sample 
QKP1 is the same as that of patient 1. Patient 5 fi ts in the 
genotype cluster in the Netherlands, as does patient 2. The 
sheep reported by Klaassen et al. did not abort, and their 
samples show a difference of 1 repeat on Ms34 compared 
with CbNL01. On the basis of the comparison of MLVA 
types on 9 loci (Figure 4), all genotypes in this study can 
be distinguished. The most predominant genotype CbNL01 
clusters with other genotypes (CbNL02–CbNL09, 
CbNL11) and with 1 human sample (Cb#97) from France. 
CbNL01 differed from this human isolate on 2 loci 
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Figure 3. Phylogenetic tree with genotypes of Coxiella burnetii that 
are most closely related to the Dutch genotypes on the basis of 
4 multilocus variable-number tandem-repeat analyses (MLVA). 
Genotypes are derived from the Multiple Loci VNTR Analysis 
databases for genotyping (http://minisatellites.u-psud.fr/MLVAnet/
querypub1.php: Coxiella2009_Netherlands [accessed 2011 Jan 
11]). Repeats per locus are shown; open spots indicate missing 
values. NL, the Netherlands.
Figure 4. Phylogenetic tree with genotypes of Coxiella burnetii that 
are most closely related to the Dutch genotypes on the basis of 
9 multilocus variable-number tandem-repeat analyses (MLVA). 
Genotypes are derived from the Multiple Loci VNTR Analysis 
databases for genotyping (http://minisatellites.u-psud.fr/MLVAnet/
querypub1.php: Coxiella2007 [accessed 2011 Jan 11]). Repeats 
per locus are shown; open spots indicate missing values. NL, the 
Netherlands; Slovak Rep, Slovak Republic.
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(Ms30 and 36), which shows that the most predominant 
genotype in the Netherlands is unique. Whether this fi nding 
can be attributed to the small number of strains and clinical 
samples typed or is really a unique genotype is not yet clear. 
The closest relation to an isolate from France might give a 
clue about the origin of the genotype from the Netherlands.
The human Q fever outbreak in the Netherlands started 
in the southern part of the country and resulted in >3,500 
human cases during 2007–2010. Dairy goats and dairy sheep 
are considered to be the source of this outbreak, primarily 
on the basis of epidemiologic fi ndings (10,17,20,21,25,26). 
In our study, samples were typed from farms suspected of 
being the source of the human Q fever outbreak. Results 
show that 1 genotype of C. burnetii predominated in the 
dairy goats and sheep in the human Q fever outbreak area 
in the southern part of the Netherlands, and this genotype 
also was present in a human case-patient in the Netherlands. 
This C. burnetii genotype is expected to have played a 
key role in the Q fever outbreak in small ruminants in the 
Netherlands and was also transmitted widely to humans, 
causing Q fever in the human population. If this hypothesis 
holds true, C. burnetii with the same genotype as in dairy 
goats should be found in most samples from human Q fever 
patients. To this end, a study was performed to show the 
genetic background of human C. burnetii isolates in the 
Netherlands by using a concordant MLVA typing method 
(J.J.H.C. Tilburg et al., unpub. data). Furthermore, the 
uniqueness of the predominant genotype of C. burnetii 
for the Netherlands can be part of the explanation why the 
magnitude of the Q fever outbreak in the Netherlands has 
never been seen elsewhere.
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